Posted on 10/18/2021 2:46:45 PM PDT by ealgeone
The FDA this week said that Lupin Pharmaceuticals is recalling batches of its Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets. Doctors use the medication to treat hypertension, low blood pressure, and symptoms in patients with type 2 diabetes.
An analysis of the medication revealed that some batches had excessive levels of N-nitrosoirbesartan. The FDA notes that the substance is a probable human carcinogen. Lupin says that it’s received 4 incident reports of illness from Irbesartan tablets. The company hasn’t seen any illness reports from the Irbesartan and Hydrochlorothiazide medication.
Possible symptoms from the medication include excitation and depression. More serious symptoms include “bradycardia, hypotension, and even cardiovascular collapse.”
(Excerpt) Read more at msn.com ...
That was my first thought too! ...although for the numbers they cite you’d think they leave themselves open to legal action considering the numbers for COVID.
That’s what I was thinking, that someone doctor has stumbled upon them being an effective covid supplemental medication and FDA is just getting ahead of it.
It’s going to take decades for FDA and CDC to win back public trust, if they ever can.
Weren’t these already approved by the FDA?
Don’t worry about, trust the science!
yeppers!
trust fauzi!!! LOL!!
As usual, the cure is worse than the ailment.
Maybe the ppl with cancer from the medication were also vaccinated. Hmm...
Safe and effective.
and FDA approved....because they followed....THE SCIENCE.
I take 10 mg of Lisinopril daily for blood pressure. It’s been around for many decades and is proven safe and effective.
Officially there are only two deaths from the injection. They have to do autopsies they refuse to do them. The two doctors that did those two lost their job
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.